A phase II trial using etanercept, a recombinant tumour necrosis factor antagonist, in metastatic breast cancer

Bibliographic Details
Main Authors:	Forster, MD, Braybrooke, J, Madhusudan, S, Kaur, K, Hoare, S, Balkwill, F, Ganesan, T, Talbot, D, Harris, A
Format:	Journal article
Published:	2002

Similar Items